Combined Patterns of IGHV Repertoire and Cytogenetic/Molecular Alterations in Monoclonal B Lymphocytosis versus Chronic Lymphocytic Leukemia

Background Chronic lymphocytic leukemia (CLL)-like monoclonal B lymphocytosis (MBL) with (MBLhi) or without (MBLlo) absolute B-lymphocytosis precedes most CLL cases,the specific determinants for malignant progression remaining unknown. Methodology/Principal Findings For this purpose, simultaneous iFISH and molecular analysis of well-established cytogenetic alterations of chromosomes 11, 12, 13, 14 and 17 together with the pattern of rearrangement of the IGHV genes were performed in CLL-like cells from MBL and CLL cases. Our results based on 78 CLL-like MBL and 117 CLL clones from 166 subjects living in the same geographical area, show the existence of three major groups of clones with distinct but partially overlapping patterns of IGHV gene usage, IGHV mutational status and cytogenetic alterations. These included a group enriched in MBLlo clones expressing specific IGHV subgroups (e.g. VH3-23) with no or isolated good-prognosis cytogenetic alterations, a second group which mainly consisted of clinical MBLhi and advanced stage CLL with a skewed but different CLL-associated IGHV gene repertoire (e.g. VH1-69), frequently associated with complex karyotypes and poor-prognosis cytogenetic alterations, and a third group of clones with intermediate features, with prevalence of mutated IGHV genes, and higher numbers of del(13q)+ clonal B-cells. Conclusions/Significance These findings suggest that the specific IGHV repertoire and IGHV mutational status of CLL-like B-cell clones may modulate the type of cytogenetic alterations acquired, their rate of acquisition and/or potentially also their clinical consequences. Further long-term follow-up studies investigating the IGHV gene repertoire of MBLlo clones in distinct geographic areas and microenvironments are required to confirm our findings and shed light on the potential role of some antigen-binding BCR specificities contributing to clonal evolution.

[1]  Armin A. Weiser,et al.  Influence of antigen on the development of MALT lymphoma. , 2006, Blood.

[2]  Marcos González,et al.  Increased frequency (12%) of circulating chronic lymphocytic leukemia-like B-cell clones in healthy subjects using a highly sensitive multicolor flow cytometry approach. , 2009, Blood.

[3]  A. Órfão,et al.  Impact of trisomy 12, del(13q), del(17p), and del(11q) on the immunophenotype, DNA ploidy status, and proliferative rate of leukemic B‐cells in chronic lymphocytic leukemia , 2008, Cytometry. Part B, Clinical cytometry.

[4]  Xiao-Jie Yan,et al.  From bloodjournal.hematologylibrary.org at PENN STATE UNIVERSITY on February 21, 2013. For personal use only. , 2007 .

[5]  C. Pascutto,et al.  Splenic marginal zone lymphoma: Clinical clustering of immunoglobulin heavy chain repertoires. , 2009, Blood cells, molecules & diseases.

[6]  S. de Sanjosé,et al.  Common Infectious Agents and Monoclonal B-Cell Lymphocytosis: A Cross-Sectional Epidemiological Study among Healthy Adults , 2012, PloS one.

[7]  T. Kalina,et al.  EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols , 2012, Leukemia.

[8]  T. Haferlach,et al.  Monoclonal B‐cell lymphocytosis is closely related to chronic lymphocytic leukaemia and may be better classified as early‐stage CLL , 2012, British journal of haematology.

[9]  Gunnar Wrobel,et al.  Automated array-based genomic profiling in chronic lymphocytic leukemia: development of a clinical tool and discovery of recurrent genomic alterations. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[10]  Muller Fabbri,et al.  A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. , 2005, The New England journal of medicine.

[11]  A. Rawstron,et al.  The biological and clinical relationship between CD5+23+ monoclonal B‐cell lymphocytosis and chronic lymphocytic leukaemia , 2007, British journal of haematology.

[12]  T. Shanafelt,et al.  Monoclonal B-cell lymphocytosis (MBL): biology, natural history and clinical management , 2010, Leukemia.

[13]  G. Marti,et al.  Immnuophenotypic and Gene Expression Analysis of Monoclonal B Cell Lymphocytosis Shows Biologic Characteristics Associated With Good Prognosis CLL , 2011, Leukemia.

[14]  C. E. Pedreira,et al.  CLL-like B-lymphocytes are systematically present at very low numbers in peripheral blood of healthy adults , 2011, Leukemia.

[15]  S. Richards,et al.  Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia. , 2008, The New England journal of medicine.

[16]  Deborah A. Bowen,et al.  Brief report: natural history of individuals with clinically recognized monoclonal B-cell lymphocytosis compared with patients with Rai 0 chronic lymphocytic leukemia. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  R. Dalla‐Favera,et al.  Mutations of NOTCH 1 are an independent predictor of survival in chronic lymphocytic leukemia , 2012 .

[18]  T. Kipps,et al.  Evidence for somatic selection of natural autoantibodies , 1992, The Journal of experimental medicine.

[19]  L. Pasqualucci,et al.  Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation , 2011, The Journal of experimental medicine.

[20]  T. Shanafelt,et al.  MBL or CLL: which classification best categorizes the clinical course of patients with an absolute lymphocyte count >or= 5 x 10(9) L(-1) but a B-cell lymphocyte count <5 x 10(9) L(-1)? , 2008, Leukemia research.

[21]  P. Ghia,et al.  CLL-like monoclonal B-cell lymphocytosis: are we all bound to have it? , 2010, Seminars in cancer biology.

[22]  J. Dongen,et al.  Incomplete DJH rearrangements of the IgH gene are frequent in multiple myeloma patients: immunobiological characteristics and clinical implications , 2003, Leukemia.

[23]  Neil E Caporaso,et al.  B-cell clones as early markers for chronic lymphocytic leukemia. , 2009, The New England journal of medicine.

[24]  A. Órfão,et al.  Non‐CLL‐like monoclonal B‐cell lymphocytosis in the general population: Prevalence and phenotypic/genetic characteristics , 2010, Cytometry. Part B, Clinical cytometry.

[25]  H. Döhner,et al.  Importance of genetics in chronic lymphocytic leukemia. , 2011, Blood reviews.

[26]  K. Stamatopoulos,et al.  Chronic lymphocytic leukaemia: an immunobiology approach. , 2008, Srpski arhiv za celokupno lekarstvo.

[27]  K. Stamatopoulos,et al.  Immunogenetics shows that not all MBL are equal: the larger the clone, the more similar to CLL. , 2013, Blood.

[28]  J. Whitesides,et al.  Single cell analysis reveals oligoclonality among “low count” monoclonal B cell lymphocytosis , 2009, Leukemia.

[29]  Göran Roos,et al.  Subsets with restricted immunoglobulin gene rearrangement features indicate a role for antigen selection in the development of chronic lymphocytic leukemia. , 2004, Blood.

[30]  Kostas Stamatopoulos,et al.  Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies. , 2012, Blood.

[31]  A Orfao,et al.  Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation , 2002, Leukemia.

[32]  P. Musto,et al.  Monoclonal B-Cell Lymphocytosis , 2014, Translational medicine @ UniSa.

[33]  Luca Laurenti,et al.  Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia. , 2012, Blood.

[34]  B. Sarina,et al.  Impact of B-cell count and imaging screening in cMBL: any need to revise the current guidelines? , 2012, Leukemia.

[35]  E S Costa,et al.  Automated pattern-guided principal component analysis vs expert-based immunophenotypic classification of B-cell chronic lymphoproliferative disorders: a step forward in the standardization of clinical immunophenotyping , 2010, Leukemia.

[36]  Luca Laurenti,et al.  NOTCH1 mutations in +12 chronic lymphocytic leukemia (CLL) confer an unfavorable prognosis, induce a distinctive transcriptional profiling and refine the intermediate prognosis of +12 CLL , 2012, Haematologica.

[37]  M Hummel,et al.  Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936 , 2003, Leukemia.

[38]  K. Stamatopoulos,et al.  The immunoglobulin gene repertoire of low-count chronic lymphocytic leukemia (CLL)-like monoclonal B lymphocytosis is different from CLL: diagnostic implications for clinical monitoring. , 2009, Blood.

[39]  S. Stilgenbauer,et al.  Immunoglobulin Heavy Chain Variable Gene Usage and (Super)-antigen Drive in Chronic Lymphocytic Leukemia , 2010, Clinical Cancer Research.

[40]  Paolo Ghia,et al.  Diagnostic criteria for monoclonal B‐cell lymphocytosis , 2005, British journal of haematology.